Does Tirzepatide Cause Less Muscle Loss Than Semaglutide?

No large trial has been built to compare muscle loss on tirzepatide and semaglutide, so nobody can say yet that one spares more muscle. In separate trials, about a quarter of the weight people lost on tirzepatide was lean tissue, compared with about 45% on semaglutide. Measured against their own lean mass, people on both drugs lost around 11 to 13%. What the research does tie to keeping muscle on either shot is eating enough protein and doing strength training.

Has any study compared muscle loss on tirzepatide and semaglutide head to head?

Not in a way that settles it. The big head-to-head weight loss trial did not measure muscle. In the SURMOUNT-5 trial, 751 adults with obesity but without type 2 diabetes took the highest dose they could tolerate of either drug once a week for 72 weeks. For tirzepatide that was 10 or 15 mg. For semaglutide it was 1.7 or 2.4 mg.

People on tirzepatide lost 20.2% of their body weight on average, compared with 13.7% on semaglutide. Tirzepatide also took 18.4 cm off the waist, compared with 13.0 cm on semaglutide.

The published results report weight and waist size, not muscle or lean mass. So the muscle question is still open.

What the two drugs share is on their labels. The Zepbound prescribing label says tirzepatide lowers body weight with more fat loss than lean loss, and the Wegovy label says the same for semaglutide.

Lean mass is not the same thing as muscle. The trials measured it with DXA, a low-dose X-ray body scan. DXA picks up lean soft tissue, which includes organs and water as well as muscle. Measuring muscle directly takes an MRI or CT scan, as a case series on lean tissue during GLP-1 weight loss explains.

Why does tirzepatide look better for muscle in the numbers online?

The numbers online put two different trials side by side. Here is what each trial found, from a 2024 review of lean mass on these drugs:

Those rows come from different trials with different people, so they are not a direct comparison. Look at the lean mass row instead of the last one. Measured as a share of each person's own lean mass, the losses were similar: about 11% on tirzepatide and about 13% on semaglutide, according to a review of ways to limit muscle loss on these drugs.

Other studies came out differently. One study in people with type 2 diabetes compared semaglutide 1 mg and tirzepatide with placebo. Lean loss was about 15% or less of the total weight lost in every group. The authors of the 2024 review say lean mass results vary widely from trial to trial.

That same review included MRI studies and concluded that muscle changes on these drugs look adaptive. The muscle lost was in line with age and the amount of weight lost. Muscle quality likely improved too, because less fat sat inside the muscle.

How much muscle can you lose on a GLP-1, and why does it matter after 30?

In the big 68- to 72-week trials, people lost an estimated 10% or more of their muscle mass. That is roughly the muscle an adult over 30 loses in 20 years of aging, at an estimated 3 to 5% per decade, according to the review of ways to limit muscle loss.

Muscle burns more energy than fat. Lose it, and the weight gets harder to keep off. If you stop treatment and regain, that weight is likely to be mostly fat.

The lose-and-regain cycle is especially common in women under 60. Severe weight cycling is linked to a higher risk of muscle loss over time.

So the goal is to lose fat and keep the muscle that gives you shape and strength, whichever shot you take.

How do you keep your muscle on tirzepatide or semaglutide?

Eat enough protein and lift weights. Here is what supports that:

• Experts recommend it for everyone on these drugs. The review of ways to limit muscle loss says everyone taking them for weight loss should get enough protein and nutrients and do resistance training to protect muscle and strength.
• A clinic group held steady after six months. In a real-world study of 269 adults on semaglutide or tirzepatide (78% women, average age 41), people were told to eat 60 to 90 g of protein a day and strength train at least twice a week. Their muscle dipped in the first 6 months, then held steady from 6 to 12 months. The study had no comparison group, so it shows what happened, not proof that the routine caused it.
• Some people gained lean tissue while losing weight. In the case series, three people on semaglutide or tirzepatide lifted 3 to 5 days a week and ate more protein. Two gained lean tissue (2.5% and 5.8%) while losing weight. The third lost 8.7% of their weight as lean tissue. Three people is a small sample, but it shows muscle loss is not automatic.
• One woman leaned into lifting. A 38-year-old on Zepbound wrote: "Weight loss slowed to about 4-6 lbs a month for the last 5 or so months, but I upped my strength training at that time as well."
• Put protein first. When the shot kills your appetite, eat the protein on your plate first at each meal so it does not get crowded out.

So should you choose tirzepatide or semaglutide?

Choose on what has been compared head to head, and on how you handle each drug. In SURMOUNT-5, tirzepatide led to more weight and waist loss. People on it were also more likely to lose at least 10%, 15%, 20% and 25% of their body weight.

A real-world clinic saw a similar pattern. At 12 months, people on tirzepatide had lost 22% of their weight, compared with about 12% on semaglutide. Women lost more than men.

Side effects on both drugs were mostly stomach and gut problems. Most were mild to moderate and showed up mainly while the dose was being increased.

You take one or the other, not both. The Zepbound label says tirzepatide should not be combined with other GLP-1 medicines. Neither drug is for you if you or a family member has had medullary thyroid cancer, or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2), an inherited condition.

Our clinical team can prescribe semaglutide or tirzepatide if it fits your goal. They can also help you set up the protein and strength routine that protects your muscle on either one.

You want to lose the fat and keep the shape your muscle gives you. Take the quiz so our clinical team can see whether semaglutide or tirzepatide fits your goal and build your plan around keeping your muscle while you lose.